Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 24 for “"Neu1"”.
-
Interactions of NEU1 with ASGR and LDLR
… studies in our laboratory have shown that NEU1 down regulation leads to LDLR hypersialylation which results in its stabilization via reduced interactions with PCSK9. New evidence suggests that NEU1 which de-sialylates LDLR, may affect the ability of another hepatic receptor, the …
-
The Role of Neu1 Sialidase in Toll-Like Receptor Activation
… cellular sialidase, which we have identified as Neu1 sialidase, which specifically targets and hydrolyses alpha-2,3-linked sialic acid residues on the receptor. Blocking Neu1 sialidase activity with specific inhibitor Tamiflu detrimentally impacts ligand-induced TLR4/MyD88 interaction, NFkappaB …
-
Developmental Characterization of the Choroid Plexus in Sialidosis (Neu1 Deficient) Mice
The lysosomal sialidase Neuraminidase-1 (Neu1) initiates the hydrolysis of sialoglycoconjugates by cleaving their terminal sialic acid residues. Neu1 creates a complex with the carboxypeptidase protective protein/cathepsin A (PPCA), which is necessary for its catalytic activation and its transport …
-
The Role of Neu1 Sialidase in Epidermal Growth Factor Receptor Activation
… and activation remain unknown. Recently, Neu1 sialidase, an enzyme which cleaves α-2,3-linked sialic acids from glycosylated substrates, has been implicated as a critical mediator of TrkA receptor activation. Upon activation, the sialidase desialylates the external receptor glycosylation, …
-
The Role of Neu1 Sialidase in Trk Tyrosine Kinase Receptor Activation
… unknown. In this thesis, the novel role of Neu1 sialidase in the activation of ligand-induced TrkA and TrkB receptors has been identified. It has been reported for the first time that Neu1 is already in complex with naïve and ligand-induced Trk receptors. In addition, a membrane sialidase …
-
NOVEL ROLES FOR NEU1 SIALIDASE IN LIPOPROTEIN METABOLISM AND INFLAMMATION: BRIDGING MOLECULAR MECHANISMS IN ATHEROSCLEROSIS
… in monocytes coupled with an up-regulation of Neu1. Inhibition of sialidase using DANA attenuated VLDL-induced monocyte differentiation and lipid uptake, as well as activation of macrophages, implicating Neu1 in inflammatory processes associated with initiation of atherosclerosis. Furthermore, …
-
Immunomodulatory Roles of the Lysosomal Sialidase Neuraminidase 1
… subcellular compartments. Neuraminidase 1 (NEU1), the most abundant and ubiquitous of the four sialidases, functions primarily in the acidic environment of the lysosomes, but can hydrolyze substrates at the plasma membrane, at least in certain cell types. The enzyme initiates the sequential …
-
Neuraminidase-1 Sialidase and Matrix Metalloproteinase-9 Crosstalk in Alliance With Insulin Receptors is an Essential Molecular Signaling Platform for Insulin-Induced Receptor Activation
… by insulin binding to its receptor to induce Neu1 in live HTC-IR and MiaPaCa-2 cell lines. Microscopy colocalization and co-immunoprecipitation analyses reveal that Neu1 and MMP9 form a complex with naïve and insulin-treated receptors. Tamiflu (neuraminidase inhibitor), galardin and piperazine …
-
NEU1 Sialidase and Matrix Metalloproteinase-9 Cross-Talk is Essential for Toll-Like Receptor Activation and Cellular Signaling
… reports have identified that neuraminidase-1 (NEU1) is an important intermediate in the initial process of TLR ligand induced receptor activation and subsequent cell function. What we do not yet understand is how NEU1 is activated following TLR ligand binding. In this thesis, the findings …
-
Caffeine Binding Non-Canonical Biased Adenosine A₂AR GPCR Modulates Neu1 Activation and Signaling in Breast Cancer Cells
… metalloproteinase‑9 (MMP9), and neuraminidase‑1 (Neu1) to modulate cancer‑associated phenotypes in breast cancer cells. Using sialidase assays, we found that caffeine induced Neu1 enzymatic activity in both MDA‑MB‑231 (TNBC) and MCF‑7 (luminal) cells in a dose‑dependent manner. This induction was …
-
Role of Neuraminidase-1 in Cancer Development and Clinical Implications
… enzyme in mammalian cells, neuraminidase-1 (Neu1), has been shown to positively regulate several receptors and their activation, including the epidermal growth factor receptor (EGFR), insulin receptor (IR), and a number of TOLL-like receptors (TLR). Notably, these receptors each play unique …
-
Cannabinoid Type 2 Receptors Promote Cadherin Switching While Suppressing Cell Migration: A Novel Investigation into Biased GPCR Signaling
… (NMBR), in complex with neuraminidase 1 (Neu1) and matrix metalloproteinase 9 (MMP9). This crosstalk facilitated the glycosylated receptor activation and downstream gene regulation mediated by nuclear factor kappa B (NF-κB). Importantly, cannabinoid type 1 (CB1) receptors have been …
-
Characterisation of a Lysosomal Sialidase, G9 (NEU)
… indicates that it corresponds to the <em>Neu1</em> gene, which was mapped to the S region of the H-2 complex (the murine MHC class III region) by genetic linkage studies and analysis of <em>Neu1</em> phenotypes in mice, and has been shown to modulate the sialic acid content of several …
-
Estrone Sulfate Uses a Biased GPCR Signalling Paradigm to Modulate Triple-Negative Breast Cancer Progression
… metalloproteinase 9 (MMP9), and neuraminidase 1 (Neu1) crosstalk, a signalling paradigm with previously established stoichiometry conducive to biased signalling in response to a variety of agonists like cannabinoids and artificial sweeteners. To determine if E1S employs the proposed NMBR/MMP9/Neu1 …
-
Tay-Sachs Disease: Mechanisms of Neuropathology and Potential Therapeutic Strategies Utilizing Human Lysosomal Sialidase
… augmented neuraminidase 1/lysosomal sialidase (NEU1) protein levels, which reduced intralysosomal GM2 accumulations. Chromatin immunoprecipitation revealed binding of CDP<sup>831-1505</sup> to the human <em>NEU1</em> promoter in Tay-Sachs neuroglia. These results provide mechanistic and …
-
Delivery of oseltamivir phosphate and gemcibatine from implantable poly (D,L-lactic-co-glycolic acid) cylinders for the treatment of pancreatic cancer
… have indicated mammalian neuraminidase 1 (Neu1) as a potential therapeutic target due to its role in receptor tyrosine kinase activation. OP inhibits Neu1 and has shown promise as a therapeutic agent for the treatment of pancreatic cancer. In vitro experiments have indicated combined …
-
Reframing viral infections as acute metabolic disorders: dengue viruses and their dependency on host metabolic pathways
… between DENVs and the human sialidase enzymes (NEU1-4). While previously studies linked upregulation of these enzymes with DENV2 pathology, we provide the first evidence showing that NEU1-4 functionality is vital for DENV2 genome replication and viral egress. Moreover, our analyses also revealed …
-
Mechanism and therapy of elastin fragments induced joint degeneration
… neutralisation and inhibition of elastase/NEU1 as candidate disease-modifying strategies, and they suggest ECM fragments as measurable biomarkers for early diagnosis and treatment monitoring.
-
Modification of Alginate and Development of Polymeric Nanocarriers by Living Radical Polymerization for Controlled/Targeted Drug Delivery
… Oseltamivir phosphate targets and inhibits Neu1 sialidase activity associated with receptor tyrosine kinases such as epidermal growth factor (EGF) receptors which are overexpressed on cancer cells. By decorating micelles with oseltamivir, it was found that micelles actively targeted human …
-
Elucidating Eukaryotic Chemorepulsion
… also explored the effect of human sialidases NEU1-4 on neutrophil priming. I found that NEU3, previously shown to be upregulated in fibrosis, primes neutrophils and increases expression of neutrophil markers CD11b, CD18, and CD66a to localize to the cell cortex, and decreases the localization …
Page 1 of 2